Biological activities of guanidine compounds, 2008–2012 update

F Sączewski, Ł Balewski - Expert opinion on therapeutic patents, 2013 - Taylor & Francis
Introduction: Compounds incorporating guanidine moiety have found many practical
applications in diverse areas of chemistry, such as nucleophilic organocatalysis, anion …

Inducible RNAi system and its application in novel therapeutics

Y Liao, L Tang - Critical reviews in biotechnology, 2016 - Taylor & Francis
RNA interference (RNAi) was discovered as a cellular defense mechanism more than
decade ago. It has been exploited as a powerful tool for genetic manipulation. Characterized …

The histone demethylase JMJD2A modulates the induction of hypertrophy markers in iPSC-derived cardiomyocytes

W Rosales, F Lizcano - Frontiers in Genetics, 2018 - frontiersin.org
The development of cardiovascular pathologies is partly attributed to epigenetic causes,
including histone methylation, which appears to be an important marker in hearts that …

KDM4C activity modulates cell proliferation and chromosome segregation in triple-negative breast cancer

J Garcia, F Lizcano - Breast cancer: basic and clinical …, 2016 - journals.sagepub.com
The Jumonji-containing domain protein, KDM4C, is a histone demethylase associated with
the development of several forms of human cancer. However, its specific function in the …

Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification

F Lizcano, L Bustamante - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Epigenetic changes induced by environmental factors are increasingly relevant in
cardiovascular diseases. The most frequent molecular component in cardiac hypertrophy is …

Role of histone demethylases in cardiomyocytes induced to hypertrophy

W Rosales, J Carulla, J García… - BioMed Research …, 2016 - Wiley Online Library
Epigenetic changes induced by histone demethylases play an important role in
differentiation and pathological changes in cardiac cells. However, the role of the jumonji …

Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia

S Xu, C Zhou, R Liu, Q Zhu, Y Xu, F Lan… - Bioorganic & Medicinal …, 2018 - Elsevier
Histone lysine specific demethylase 1 (LSD1) is overexpressed in diverse hematologic
disorders and recognized as a promising target for blood medicines. In this study, molecular …

Comparative QM/MM molecular dynamics and umbrella sampling simulations: Interaction of the zinc-bound intermediate gem-diolate trapoxin A inhibitor and acetyl-l …

WA Zalloum, N Zalloum - The Journal of Physical Chemistry B, 2021 - ACS Publications
Targeting the genetic material without destruction is a priority to develop safe anticancer
drugs. Histone deacetylase 8 (HDAC8), which is proved to be involved in carcinogenesis, is …

KDM1A inhibitors for the treatment of disease

JM McCall, HY Rienhoff Jr, M Clare - US Patent 9,790,195, 2017 - Google Patents
US9790195B2 - KDM1A inhibitors for the treatment of disease - Google Patents
US9790195B2 - KDM1A inhibitors for the treatment of disease - Google Patents KDM1A …

Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array

M Partolina, HC Thoms, KG MacLeod… - Cell Death …, 2017 - nature.com
The balance between acetylation and deacetylation of histone proteins plays a critical role in
the regulation of genomic functions. Aberrations in global levels of histone modifications are …